Search

everythinglearnresearchcommunity

for

Search:↓

People with pemphigus vulgaris and pemphigus foliaceus often have smaller sebaceous glands on their scalp.

The study found that balding scalps have more thin hairs and larger oil glands, which might contribute to skin conditions related to hair loss.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Sebaceous glands in male pattern hair loss patients have more lobules and might cause early hair growth phase shifts.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Multiphoton microscopy can non-invasively tell apart scarring from non-scarring hair loss and could aid in treatment.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Androgens and other hormones affect hair growth and skin conditions like acne.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.

Transplanted hair follicles show significant changes after FUE, needing more research.

Hair loss and aging are caused by the breakdown of a key protein in hair stem cells.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

UV exposure causes hair thinning, graying, and changes in hair growth cycles in mice.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Chemotherapy caused a woman's permanent hair loss and early menopause.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Convolvulus arvensis ethanolic extract can potentially promote hair growth and reduce hair loss.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Understanding hair biology is key to developing better treatments for hair and scalp issues.

Examining scalp biopsies in different ways helps better diagnose hair loss types.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.

Different types of dog hair loss are linked to problems starting the hair growth phase and early hair cycle ending.